Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7276
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater, among others. It utilizes micro-delivery and color touchscreen technologies. Tandem also provides infusion set, which is a 90° flexible soft cannula. The company offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US.

Tandem Diabetes Care Inc (TNDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Venture Financing 12
Tandem Diabetes Care Raises US$36.4 Million In Series D Financing 12
Partnerships 13
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Equity Offering 18
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For US$138 Million 28
Tandem Diabetes Care Inc – Key Competitors 30
Tandem Diabetes Care Inc – Key Employees 31
Tandem Diabetes Care Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Jul 30, 2018: Tandem Diabetes Care Reports Second Quarter 2018 Financial Results 33
Apr 26, 2018: Tandem Diabetes Care Reports First Quarter 2018 Financial Results 34
Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 35
Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 36
Jan 09, 2018: Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance 38
Oct 26, 2017: Tandem Diabetes Care Reports Third Quarter 2017 Financial Results 39
Jul 27, 2017: Tandem Diabetes Care Reports Second Quarter 2017 Financial Results 41
Apr 27, 2017: Tandem Diabetes Care Reports First Quarter 2017 Financial Results 42
Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 44
Corporate Communications 46
Dec 07, 2017: Tandem Diabetes Care CFO to Retire, Successor Named 46
Product News 47
Dec 14, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology 47
Aug 24, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps 48
Aug 08, 2017: Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control 49
Feb 15, 2017: Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump over Medtronic MiniMed SAPs 50
Other Significant Developments 51
Jan 03, 2018: Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Tandem Diabetes Care Inc, Medical Equipment, Key Facts, 2017 2
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Deals By Market, 2012 to YTD 2018 9
Tandem Diabetes Care Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Tandem Diabetes Care Acquires US Patents And Patent Applications From Smiths Medical 11
Tandem Diabetes Care Raises US$36.4 Million In Series D Financing 12
Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 13
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 14
Tandem Diabetes Amends Licensing Agreement With DexCom 15
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 16
Tandem Diabetes Enters Into Co-Development Agreement With JDRF For Dual-Chamber Infusion Pump 17
Tandem Diabetes Care Rises USD115 Million in Public Offering of Shares 18
Tandem Diabetes Care Raises USD69 Million in Public Offering of Shares 19
Tandem Diabetes Care Plans to Raise USD10.7 Million in Public Offering of Securities 20
Tandem Diabetes Care Prices Public Offering of Shares for USD16.2 Million 21
Tandem Diabetes Care Plans to Raise up to USD15 Million in Public Offering of Shares 23
Tandem Diabetes Care Raises USD23 Million in Public Offering of Shares 24
Tandem Diabetes Raises USD69.4 Million in Public Offering of Shares 26
Tandem Diabetes Care Completes IPO For US$138 Million 28
Tandem Diabetes Care Inc, Key Competitors 30
Tandem Diabetes Care Inc, Key Employees 31

List of Figures
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tandem Diabetes Care Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Tandem Diabetes Care Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Tandem Diabetes Care Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Tandem Diabetes Care Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dassault Systemes SA:企業の戦略・SWOT・財務情報
    Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report Summary Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sahara Petrochemicals Co:企業の戦略的SWOT分析
    Sahara Petrochemicals Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Del Taco Holdings, Inc.:企業の戦略・SWOT・財務情報
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wausau Paper Corporation:企業の戦略・SWOT・財務情報
    Wausau Paper Corporation - Strategy, SWOT and Corporate Finance Report Summary Wausau Paper Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Source BioScience Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Source Bioscience Ltd (Source BioScience), a subsidiary of Sherwood Holdings Ltd is a provider of laboratory products and services. The company offers life science research, clinical product, and controlled environment products. Its life science research products include antibodies, clones, …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Bank Dhofar SAOG:企業の戦略・SWOT・財務分析
    Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report Summary Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bdo Unibank Inc:企業の戦略・SWOT・財務分析
    Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary Bdo Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Atlas Copco AB (ATCO A):企業の財務・戦略的SWOT分析
    Atlas Copco AB (ATCO A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • Cogstate Ltd (CGS):医療機器:M&Aディール及び事業提携情報
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Allegra Orthopaedics Ltd (AMT):医療機器:M&Aディール及び事業提携情報
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dompe Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Dompe Farmaceutici SpA (Dompe) is a developer of therapeutic solutions that research novel therapies for the treatment of rare and orphan diseases. The company provides product pipeline such as C5aR Antagonists, TRPM8 Blockers pain, TRPM8 Blockers urology, BKB1R Antagonists, CNR2 Agonists an …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆